# Integration of Dose-Counting Mechanisms into MDI Drug Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/integration-of-dose-counting-mechanisms-into-mdi-drug-products/b523d7a1-3c0a-423e-ac27-f899492e96ff

> FDA guidance document: Integration of Dose-Counting Mechanisms into MDI Drug Products. Issue date: March 13, 2003. Get complete insights and analysis.

---

## Details

- Title: Integration of Dose-Counting Mechanisms into MDI Drug Products
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2003-03-13
- Last Changed: 2022-02-25
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2003-D-0285">FDA-2003-D-0285</a>

## Related Documents

- [Statistical Approaches to Establishing Bioequivalence](https://www.globalkeysolutions.net/guidances/guidance-document/statistical-approaches-to-establishing-bioequivalence/3391de1a-8097-49d5-83f8-195b2013a5e2)
- [Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies](https://www.globalkeysolutions.net/guidances/guidance-document/potassium-iodide-as-a-thyroid-blocking-agent-in-radiation-emergencies/37bc2102-9236-47bf-a1a3-6fbb42443ab7)
- [Drug Products Containing Ensulizole, Hypromellose, Meradimate, Octinoxate, and Octisalate — Labeling Enforcement Policy](https://www.globalkeysolutions.net/guidances/guidance-document/drug-products-containing-ensulizole-hypromellose-meradimate-octinoxate-and-octisalate-labeling-enforcement-policy/4320b2a8-6f77-4cbf-8a20-7b9631fcf4fe)